Integrated bioanalytical solutions for drug conjugates

Drug conjugates are complex therapeutics that require a unique combination of small and large molecule bioanalytical expertise. Partner with Celerion to leverage our integrated scientific capabilities for comprehensive bioanalytical solutions and assay strategies.


Antibody drug conjugate molecular render

Bioanalytical support for complex drug conjugates


Celerion combines decades of bioanalytical expertise in both small molecules and biologics to support the evolving field of drug conjugates. By combining small and large molecule expertise within one organization, Celerion delivers scientifically integrated solutions for:

  • Antibody-Drug Conjugates (ADCs)
  • Peptide-Drug Conjugates (PDCs)
  • Small Molecule-Drug Conjugates (SMDCs)
  • Antibody-Oligonucleotide Conjugates (AOCs)
  • Protein-Drug Conjugates
  • Aptamer-Drug Conjugates

Simplify outsourcing by partnering with a single CRO that provides comprehensive bioanalytical support across the entire drug conjugate lifecycle.

Comprehensive bioanalytical solutions from a single provider


Drug Conjugates require multiple complementary bioanalytical approaches to support pharmacokinetic and immunogenicity assessment. At Celerion, we maintain top-of-the-line LCMS and immunoassay platforms in our laboratories to provide our clients with customized methods including:

  • Total Carrier (antibody, protein, etc.)
  • Conjugated Carrier
  • Total Payload
  • Unconjugated Payload
  • Anti-Drug Antibody

Celerion LCMS laboratory instrumentation

Ready to Get Started?

Connect with our scientific team to discuss how Celerion’s range of expertise can be leveraged to provide you with expert bioanalytical solutions for your Drug Conjugate program

Contact Us